2011 financial results

March 29th. 2012

Riber – march 2012 2

Contents

Profile

Business in 2011

2011 results

Growth drivers

Outlook

Stock market and shareholding

Riber – march 2012

Molecular beam epitaxy machines (MBE)

Service contracts. accessories and spare

parts

Material deposit industrial tools and

effusion cells

Development

around three product lines

3

• Technical and scientific support ;

• Technical assistance on demand for

the upgrading of systems;

• Service for preventive and curative

maintenance

RIBER is an integrated company with control

over its entire value chain

40% of 2011 revenues 42% 2011 revenues (of which 75% OLED)

19% 2011 revenues

MBE cells

Selenium deposit tools for the

manufacture of solar panels

OLED cells

Riber – march 2012 4

RF components for

telephony and

telecommunications

Lasers and diodes

for fiber-optic

Instrumentation

and lighting

Sensors for night

vision and

various detectors

Solar cells

MBE : upstream presence in the value chain

Substrate

or wafer

Source

materials

Substrates Processed

substrates

Electronic

devices

Final

applications

RF electronics

Sensors

Optoelectronics

Epitaxy

systems

Riber – march 2012 5 5

Molecular Beam Epitaxy (MBE)

Epitaxial wafer

Molecular Beam

Molecular beam shutter

Effusion cells

Growth chamber

Riber – march 2012

Cells: OEM positioning

6

© Tokki

OLED production value chain

Riber – march 2012 7 7

RIBER, an advanced industrial

RIBER is the specialist for systems producing semiconductor alloys and

depositing complex materials in ultra-thin layers

Global market leader for molecular beam epitaxy (MBE)

Recent diversification on groundbreaking technologies: equipments for production of

CIGS solar cells. OLED displays and new generation microprocessors

RIBER machines and equipment make it possible to develop very high-

performance compound materials

Quicker microprocessors and memory

Low-consumption and high-intensity lighting

Fine sensors (luminosity. magnetism. molecular structure. etc.)

RIBER. leading-edge technological expertise in the nanotechnology sector.

recognized by the best research establishments

Riber – march 2012 8 8

Global base of leading clients

Industrial players in

the electronics. new

energies and lighting

sectors

University

laboratories and

research centers

Business in 2011

Riber – march 2012

2011 highlights Effusion cells

3.1

12.1

2010 2011

10

Sales diversification on fast growing markets of OLED (€ 9.1m) and CIGS solar thin-

film (€ 1.7m).

(€m)

x4

2.2

0.6

2010 2011

-74%

Revenue as of December 31st

Order book as of December 31st

Riber – march 2012

1.8 1.4

2010 2011

2011 highlights Services and accessories lines

6.5

5.4

2010 2011

11

(€m)

-18%

Lower sales in the U.S. (major clients under hard budget constraints)

Business growth in Europe

-19%

Revenue as of December 31st

Order book as of December 31st

Riber – march 2012

2011 highlights MBE systems

6.5 5.8

4.6 5.8

2010 2011

12

7.5

13.6

5.8

3.8

2010 2011

Revenue as of December 31st

Order book as of December 31st

(€m)

Research systems Production systems

13.3

17.4

+4%

+31%

Riber – march 2012

Product mix diversification

54%

31%

15%

At 31 December 2010

42%

19%

40%

At 31 December 2011

13

Systems Services and accessories Cells

Breakdown of sales by activities

€ 29.0 m € 20.7 m

Riber – march 2012

Sales development in Asia

57% 27%

16%

At 31 December 2010

32%

52%

16%

At 31 December 2011

14

Breakdown of sales by geographic areas

Europe Asia and Pacific North America

29.0 M€ 20.7 M€

2011 results

Riber – march 2012 16 16

2011 earnings Income statement

(€m - IFRS) 2011 2010 retreated

2010 published

Revenues 29.0 20.7 +40% 20.7

Change in provisions on inventories 1.7 1.5 +15% 1.5

Gross margin % of revenues

12.4 42.9%

9.3 44.9%

+33% 9.3 44.9%

Sales and marketing costs

Research and development costs

Administrative costs

Other income and expenses

(4.3)

(1.6)

(1.9)

(0.2)

(4.5)

(1.3)

(1.6)

(0.4)

-3%

+25%

+21%

-48%

(3.8)

(2.0)

(1.5)

(0.4)

Operating income % of revenues

4.3 15.0%

1.6 7.8%

+169% 1.6 7.8%

Pre-tax earnings 4.5 1.8 +153% 1.8

Net income % of revenues

4.3 14.8%

1.8 8.6%

+141% 1.8 8.6%

EBITDA % of revenues

2.7 9.3%

1.6 7.6%

+69% 1.6 7.6%

Riber – march 2012 17 17

Very sound financial position Balance sheet at December 31, 2011

12,1

17,8

1,2

9

13,3

1,1

25,7

Fixed assets

Financial assets

Current assets

Cash and

near cash

Shareholders' equity

Non-current liabilities

Current liabilities

40.1 €m

Assets Liabilities

Balance sheet total : + €4.5 m over one year (+13%)

Shareholders' equity: + €2.9 m over one year (+13%)

Riber – march 2012 18

Growth in net cash

Change in net cash position* (€m)

3.0

5.6

9.6

11.2

2008 2009 2010 2011

* Cash – financial debt (OSEO recoverable advances)

Riber – march 2012 19 19

Stronger cash generation

(€m) 2011 2010

Operating cash flow 3.5 5.8

Of which, cash flow from operations after cost of financial debt and tax

5.0 3.5

Change in working capital - inventories

- clients

- suppliers

(1.7) (3.8)

1.0

1.1

1.0 (1.3)

(2.0)

4.3

Investing cash flow

(0.8)

(1.1)

Financing cash flow (1.1) (0.8)

Change in cash position 1.6 3.9

Opening cash position 10.5 6.6

Closing cash position 12.1 10.5

Condensed cash flow statement

Riber – march 2012

Improving financial ratios

20

(IFRS) 2011 2010 2009

Operational return on capital

Cash flow from operations / equity 19.4% 15.2% 1.6%

Cash flow

Cash flow from operations / revenues 17.2% 16.7% -1.3%

Financial independence

Equity / balance sheet total 64.0% 64.0% 73.4%

R&D

% of payroll for R&D 16.9% 17.2% 18.7%

Riber – march 2012 21

2011 Dividend

2011 2010 2009

Dividend per share € 0.08 € 0.06 € 0.04

Average stock price € 3.03 €1.82 € 1.16

Yield 2.6 % 3.3 % 3.4 %

Growth drivers

Riber – march 2012 23

Strategy of profitable growth

Developing the MBE Systems range

New applications

Clusters and instrumentation

Developing the Services business and the MBE cells range

Stronger sales drive

Rationalization of the MBE cells range

Developing the OEM Cells range

Go into production on CIGS

Take part of technological breakthrough on OLEDs in the wake of 2011 successes

New concepts for OEM MBE systems

Development of a SEMI standard compliant MBE machine

Research programs in progress via industrial partnerships

Riber – march 2012 24

Operating of core-businness:

MBE systems, cells and services

Capitalizing on technological advances for R&D and production

sales

Conquest of market shares, especially on emerging markets

Launch of MBE 8000 project in Q4 2011

Operating an installed base of around 800 MBE systems to

further strengthen services

Improving service delivery and structuring activity

Development of MBE cells sales

Maximizing revenues for spare parts, services and components

Riber – march 2012 25

Strategic positions

on high-potential applications

Supplying OEM components for OLED production

Development of dedicated cells for

manufacturing OLEDs (Organic

LEDs) Applications:

high-luminosity

flexible screens,

production of

lighting surfaces,

signage

First major Gen 5.5. cells

contracts delivered in 2011

In 2012, Gen. 8 cells technological

developments to support the next

phase of industrialization

Growing use of OLEDs

in flexible screen applications

Source : Displaysearch. Citi Investment Research and Analytics. 2011

Riber – march 2012 26

Strategic positions

on high-potential applications

Supplying OEM components for manufacturing

thin-layer solar panels (CIGS, etc.)

Development of cells for manufacturing thin-layer

solar panels with CGIS alloys high-output CIGS panels (< $1 / Watt)

Roll-to-roll industrial production

Production units at the stage of pre-production

with leading players

(Leybold Optics,

etc.)

Commercial outlets

expected in 2 years

A long-term partnership in ”Institut

Photovoltaïque d’Ile-de-France (IPVF) for

research on new generation photovoltaic devices Source : GBI Research. 2010

Thin-layer solar cell market

(installed capacity per year in MW)

0

5000

10000

15000

20000

25000

2009 2010 (p) 2012 (p) 2014 (p) 2016 (p) 2018 (p) 2020 (p)

Pro

du

ctio

n e

n M

W

Riber – march 2012 27

Development

of future MBE applications

“More than Moore” program

MBE, a response to the calculation speed and storage challenges

Applications :

• Compound semiconductor passivation

• High speed MRAM and CMOS manufacturing

Development of a range suitable for silicon producing (SEMI standards): MPV300 (MRAM) and ISA300 (CMOS)

System in qualification phase with a major industrial player in Asia (MRAM)

Research program with IMEC, world-leading research in nano-electronics and nano-technology (CMOS)

MPVD300

Outlook

28

Riber – march 2012

Order book at the end of february 2012

3

13.3

18.2

1.9

2.0

1.4

0.2

6.50.5

2010 2011 2012

29

21.8 20.1

Systems Services and accessories Cells

(€m)

5.1

Riber – march 2012 30

2015 objectives for profitable growh

2009 2010 2011 … 2015

17.3

40.0

(€m)

20.7

29.0

Revenue

X 2

+20%

+40%

Stock market and shareholding

Riber – march 2012 32 32

Change in the share price

Market capitalization: 61.6 €m (€ 3.19 per share at 27/03/2012)

Riber – march 2012

Shareholding structure

Listed on NYSE-EURONEXT Paris Eurolist C since 2000

Part of CAC Small. CAC Mid &

Small and CAC IT indexes

ISIN : FR0000075954

Reuters : RIBE.PA

Bloomberg : RIB FP

Certification by OSEO-ANVAR, the dedicated French innovation agency, renewed in July 2009

NG Investment

s 23.7%

ISA Finances

14.0%

Ormylia 9.7% Michel

Picault 5.4%

Float 47.2%

33

Shareholding Public NYSE-Euronext information

As of April 17th, NG Investments participation will be increased to 28.3% and that of

Michel Picault reduced to 0.8%

Questions and answers